Loading...

Idorsia Ltd

IDRSF•PNK
Healthcare
Biotechnology
$4.32
$0.00(0.00%)
U.S. Market opens in 2h 9m

Idorsia Ltd (IDRSF) Stock Overview

Explore Idorsia Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-7.56
EPS (TTM)$-0.66
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$4.87
3 Months$6.78
1 Year Target$6.25

IDRSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Idorsia Ltd (IDRSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.56 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
7.20%
3-Month Change
-9.05%
6-Month Change
-1.14%
Year-to-Date (YTD) Change
-17.71%
1-Year Change
332.00%
3-Year Change
-54.76%
5-Year Change
-83.69%
All-Time (Max) Change
-76.00%

Contact Information

https://www.idorsia.com
41 58 844 10 10
Hegenheimermattweg 91, Allschwil, NaN, 4123

Company Facts

1,100 Employees
IPO DateJul 17, 2017
CountryCH
Actively Trading

Frequently Asked Questions